Voyager Therapeutics (VYGR) News Today $5.75 +0.06 (+1.05%) (As of 12/20/2024 05:17 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Analysts Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $17.00December 20 at 1:31 AM | americanbankingnews.comVoyager Therapeutics, Inc. (NASDAQ:VYGR) Given Average Rating of "Buy" by AnalystsShares of Voyager Therapeutics, Inc. (NASDAQ:VYGR - Get Free Report) have been assigned an average recommendation of "Buy" from the nine research firms that are currently covering the company, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a buy recommendatioDecember 17, 2024 | marketbeat.comVoyager Therapeutics (NASDAQ:VYGR) Rating Lowered to "Hold" at StockNews.comDecember 16, 2024 | americanbankingnews.comVoyager Therapeutics (NASDAQ:VYGR) Downgraded by StockNews.com to HoldStockNews.com downgraded Voyager Therapeutics from a "buy" rating to a "hold" rating in a research report on Friday.December 13, 2024 | marketbeat.comErste Asset Management GmbH Acquires New Shares in Voyager Therapeutics, Inc. (NASDAQ:VYGR)Erste Asset Management GmbH bought a new stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,058,378 shares of the company's stock, valued atDecember 3, 2024 | marketbeat.comVoyager Therapeutics initiated with a Buy at CitiDecember 3, 2024 | markets.businessinsider.comA Glimpse Into The Expert Outlook On Voyager Therapeutics Through 5 AnalystsDecember 2, 2024 | benzinga.comCitigroup Initiates Coverage of Voyager Therapeutics (VYGR) with Buy RecommendationDecember 2, 2024 | msn.comWedbush upgrades Voyager to Outperform on pipeline progressNovember 29, 2024 | markets.businessinsider.comVoyager Therapeutics (NASDAQ:VYGR) Earns Outperform Rating from Analysts at WedbushWedbush assumed coverage on Voyager Therapeutics in a research note on Friday. They issued an "outperform" rating and a $11.00 price objective for the company.November 29, 2024 | marketbeat.comVestal Point Capital LP Sells 110,000 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR)Vestal Point Capital LP cut its holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) by 18.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 490,000 shares of the company's stock after selling 110,000 sharNovember 29, 2024 | marketbeat.comGreat Point Partners LLC Sells 641,574 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR)Great Point Partners LLC reduced its position in Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) by 40.1% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 959,953 shares of the coNovember 27, 2024 | marketbeat.comVoyager Therapeutics, Inc. (NASDAQ:VYGR) Given Consensus Recommendation of "Buy" by BrokeragesShares of Voyager Therapeutics, Inc. (NASDAQ:VYGR - Get Free Report) have been assigned an average recommendation of "Buy" from the nine research firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation, seven have assignedNovember 22, 2024 | marketbeat.comVoyager Therapeutics selects VY1706 for program in Alzheimer’s DiseaseNovember 21, 2024 | markets.businessinsider.comVoyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s DiseaseNovember 20, 2024 | finance.yahoo.comVoyager Therapeutics' TRACER Platform Targets CNS Market: Here's Why I'm NeutralNovember 18, 2024 | seekingalpha.comStockNews.com Upgrades Voyager Therapeutics (NASDAQ:VYGR) to "Buy"StockNews.com raised shares of Voyager Therapeutics from a "hold" rating to a "buy" rating in a report on Monday.November 18, 2024 | marketbeat.comHC Wainwright Has Bullish Forecast for VYGR FY2024 EarningsVoyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) - Analysts at HC Wainwright lifted their FY2024 earnings per share estimates for shares of Voyager Therapeutics in a note issued to investors on Wednesday, November 13th. HC Wainwright analyst P. Trucchio now forecasts that the company will pNovember 18, 2024 | marketbeat.comLeerink Partnrs Has Negative Outlook of VYGR FY2024 EarningsVoyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) - Leerink Partnrs lowered their FY2024 earnings per share estimates for shares of Voyager Therapeutics in a research report issued on Tuesday, November 12th. Leerink Partnrs analyst L. Nsongo now forecasts that the company will earn ($0.66) pNovember 15, 2024 | marketbeat.comDeclining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)?November 15, 2024 | finance.yahoo.comWe've been wrong about Uranus for nearly 40 years, new analysis of Voyager 2 data revealsNovember 14, 2024 | msn.comCSPD orders shelter in place around N. Academy and VoyagerNovember 14, 2024 | msn.comVoyager Therapeutics: Promising Alzheimer’s Program and Strong Financial Position Support Buy RatingNovember 14, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Voyager Therapeutics (VYGR), BioNTech SE (BNTX)November 14, 2024 | markets.businessinsider.comVoyager Therapeutics' (VYGR) Buy Rating Reiterated at Canaccord Genuity GroupCanaccord Genuity Group reiterated a "buy" rating and issued a $14.00 target price on shares of Voyager Therapeutics in a research note on Thursday.November 14, 2024 | marketbeat.comVoyager Therapeutics (NASDAQ:VYGR) Receives Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $30.00 price objective on shares of Voyager Therapeutics in a research note on Thursday.November 14, 2024 | marketbeat.comVoyager Therapeutics, Inc.: Voyager Reports Third Quarter 2024 Financial and Operating ResultsNovember 13, 2024 | finanznachrichten.deVoyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...November 13, 2024 | uk.finance.yahoo.comVoyager Therapeutics: Solid Financial Foundation and Strategic Progress Justify Buy RatingNovember 13, 2024 | markets.businessinsider.comVoyager Therapeutics Reports Strong Q3 2024 ProgressNovember 13, 2024 | markets.businessinsider.comVoyager has sufficient resources for planned operating expenses into 2027November 13, 2024 | markets.businessinsider.comVoyager Therapeutics, Inc. (VYGR) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comVoyager Reports Third Quarter 2024 Financial and Operating ResultsNovember 12, 2024 | globenewswire.comVoyager 2 is the only craft to visit Uranus. Its findings may have misled us for 40 years.November 12, 2024 | msn.comUranus and its moons may have ideal conditions for life—but Voyager 2 missed it due to one bad dayNovember 12, 2024 | msn.comUranus not a hot mess: A mistimed encounter between Voyager 2 in 1986 messed up dataNovember 12, 2024 | msn.comVoyager found a mystery on Uranus. Decades later, NASA solved it.November 12, 2024 | msn.comPreview: Voyager Therapeutics's EarningsNovember 11, 2024 | benzinga.comVoyager Therapeutics (NASDAQ:VYGR) Cut to "Hold" at StockNews.comStockNews.com downgraded Voyager Therapeutics from a "buy" rating to a "hold" rating in a research note on Sunday.November 10, 2024 | marketbeat.comUnbreakable Voyager space probes close in on a 50 year missionNovember 9, 2024 | msn.comVoyager 1 Breaks Its Silence With NASA via a Radio Transmitter Not Used Since 1981November 6, 2024 | msn.comVoyager Therapeutics (VYGR) to Release Earnings on TuesdayVoyager Therapeutics (NASDAQ:VYGR) will be releasing earnings after the market closes on Tuesday, November 12, Zacks reports.November 6, 2024 | marketbeat.comVoyager Therapeutics to Present at Multiple Upcoming Investor ConferencesNovember 6, 2024 | globenewswire.comPolice investigate body found at Interquest, Voyager in car potentially left for nearly a weekNovember 5, 2024 | msn.comVoyager Therapeutics Announces Third Quarter 2024 Conference Call and WebcastNovember 5, 2024 | globenewswire.comNasa's Voyager 1 reconnects with scientists 15 billion miles away from EarthNovember 3, 2024 | bbc.co.ukNASA's Voyager finally phoned home with a device unused since 1981November 3, 2024 | msn.comLost for almost 50 years, Nasa reconnects with Voyager 1 spacecraft 15 billion miles awayNovember 2, 2024 | msn.comStockNews.com Upgrades Voyager Therapeutics (NASDAQ:VYGR) to BuyStockNews.com raised shares of Voyager Therapeutics from a "hold" rating to a "buy" rating in a research note on Saturday.November 2, 2024 | marketbeat.comVoyager 1 reestablishes communication with Earth using backup transmitter last used in 1981November 1, 2024 | msn.com Get Voyager Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VYGR and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] VYGR Media Mentions By Week VYGR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VYGR News Sentiment▼0.500.60▲Average Medical News Sentiment VYGR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VYGR Articles This Week▼36▲VYGR Articles Average Week Get Voyager Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VYGR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ocular Therapeutix News Mesoblast News Travere Therapeutics News Intellia Therapeutics News Praxis Precision Medicines News Arvinas News Day One Biopharmaceuticals News Ardelyx News Spyre Therapeutics News ARS Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VYGR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyager Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyager Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VYGR Stock Alerts